SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation.

UNLABELLED System L amino acid transport is increased in various types of cancer. The tracer 123I-2-iodotyrosine (2IT), which is accumulated via system L, could thus serve to allow visualization of cancer in vivo. Here, we studied the transport of 125I-2IT by h4F2hc-hLAT1, the major transporter subserving system L in growing cells, using the Xenopus laevis oocyte expression system. We compared the apparent affinity of 125I-2IT with that of tyrosine, tested the influence of intracellular methionine availability on the influx rate of this substrate, and then compared the transport of 2IT with that of the other tracers-iodo-alpha-methyltyrosine (IMT), fluoroethyltyrosine (FET), and 2-fluorotyrosine (2FT)-by measuring their transstimulating effect on phenylalanine efflux. METHODS Transport experiments were performed with Xenopus laevis oocytes expressing h4F2hc-hLAT1 (the functional transporter) and oocytes expressing only h4F2hc (negative control). The values obtained for the functional transporter were corrected for endogenous background transport by subtracting the values for the negative controls. RESULTS The apparent affinity for 125I-2IT and 3H-tyrosine was 29.3 +/- 9.3 micromol/L and 21.2 +/- 4.2 micromol/L, respectively. The influx rate of 125I-2IT was, similarly to that of 3H-phenylalanine, transstimulated by a factor of > or =3 when the oocytes were preinjected with methionine or phenylalanine. The proportion of preinjected 3H-phenylalanine that effluxed within 90 s in the presence of an extracellular 2IT concentration of 0.1 mmol/L was 4.1% +/- 0.5%, compared with 3.3% +/- 0.4% for extracellular IMT, 1.3% +/- 0.3% for FET, 9.3% +/- 0.8% for 2FT, and 9.1% +/- 0.5% for phenylalanine. CONCLUSION 2IT has a high affinity for h4F2hc-hLAT1, comparable to that of natural tyrosine, and its influx rate is transstimulated by intracellular amino acids. The 2IT influx rate is comparable to that of IMT but lower than that of phenylalanine. In contrast to FET, which is only poorly transported, 2FT displays a high influx rate equal to that of phenylalanine.

[1]  P. L. Jager.  Improving amino acid imaging: hungry or stuffed? , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  H. Biersack,et al.  Simple preparation of l-3-Iodo-α-methyl tyrosine suitable for use in kit preparations , 1995 .

[3]  Y. Kanai,et al.  Characterization of 3-[125I]iodo-alpha-methyl-L-tyrosine transport via human L-type amino acid transporter 1. , 2003, Nuclear medicine and biology.

[4]  Y. Kanai,et al.  Isoform selectivity of 3-125I-iodo-alpha-methyl-L-tyrosine membrane transport in human L-type amino acid transporters. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Y. Kanai,et al.  Expression of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models , 2001, Journal of surgical oncology.

[6]  Y. Kanai,et al.  Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.

[7]  K. Langen,et al.  Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  M T Travers,et al.  Functional and molecular characteristics of system L in human breast cancer cells. , 2003, Biochimica et biophysica acta.

[9]  L. Kühn,et al.  Primary structure of the human 4F2 antigen heavy chain predicts a transmembrane protein with a cytoplasmic NH2 terminus. , 1987, The Journal of biological chemistry.

[10]  A. Luxen,et al.  Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  C. Meier,et al.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates , 2002, The EMBO journal.

[12]  Eiji Takeda,et al.  Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)* , 1998, The Journal of Biological Chemistry.

[13]  A. Bossuyt,et al.  Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  A. Bossuyt,et al.  In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport. , 2001, Nuclear medicine and biology.

[15]  F. Verrey.  System L: heteromeric exchangers of large, neutral amino acids involved in directional transport , 2003, Pflügers Archiv.

[16]  A. Krüger,et al.  O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  Y. Kanai,et al.  Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. , 2002, Molecular pharmacology.

[18]  E. Babu,et al.  Identification of a Novel System L Amino Acid Transporter Structurally Distinct from Heterodimeric Amino Acid Transporters* , 2003, Journal of Biological Chemistry.

[19]  K. Langen,et al.  3-[123I]Iodo-α-methyl-L-tyrosine: uptake mechanisms and clinical applications , 2002 .

[20]  K. Zilles,et al.  Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. , 2003, Nuclear medicine and biology.

[21]  Axel Bossuyt,et al.  Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  H. Christensen,et al.  Role of amino acid transport and countertransport in nutrition and metabolism. , 1990, Physiological reviews.

[23]  C. Shoemaker,et al.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.

[24]  D. Torrents,et al.  Identification of a Membrane Protein, LAT-2, That Co-expresses with 4F2 Heavy Chain, an L-type Amino Acid Transport Activity with Broad Specificity for Small and Large Zwitterionic Amino Acids* , 1999, The Journal of Biological Chemistry.

[25]  M. Schwaiger,et al.  Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  L. Kühn,et al.  Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity , 2000, Pflügers Archiv.